Astec Lifesciences Ltd

Astec Lifescienc Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Astec Lifesciences Ltd

₹ 619 0.19%
11 Nov - close price
astecls.com BSE: 533138 NSE: ASTEC
About

The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries.
Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B).[1] [2] [3]

Key Points

Product Portfolio
The company offers a range of products and intermediates, including fungicides, insecticides, herbicides, and various chemical compounds, serving global customers and including triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, fluorinated compounds, halides, intermediates, ketones, ethers, alcohols, and many others. [1]

Website BSE NSE
  • Market Cap ₹ 1,377 Cr.
  • Current Price ₹ 619
  • High / Low ₹ 1,254 / 607
  • Stock P/E
  • Book Value ₹ 185
  • Dividend Yield 0.00 %
  • ROCE -12.9 %
  • ROE -45.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Promoter holding has increased by 1.55% over last quarter.

Cons

  • Stock is trading at 3.34 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -6.10% over past five years.
  • Company has a low return on equity of -14.3% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
200 117 127 143 111 51 154 69 99 94 120 91 74
166 105 122 140 114 69 141 116 118 100 114 102 80
Operating Profit 33 12 5 3 -3 -18 13 -46 -20 -6 6 -11 -7
OPM % 17% 10% 4% 2% -3% -36% 8% -67% -20% -6% 5% -12% -9%
4 4 3 2 1 1 2 1 2 2 1 0 1
Interest 5 6 6 6 6 6 7 7 9 10 10 11 8
Depreciation 8 9 8 9 9 9 9 9 11 11 12 12 10
Profit before tax 25 1 -6 -11 -18 -32 -1 -62 -39 -25 -16 -33 -24
Tax % 25% 31% -19% -26% -24% -24% 3% -36% 0% 60% 3% 0% 0%
18 1 -5 -8 -13 -24 -1 -40 -39 -40 -16 -33 -24
EPS in Rs 8.17 0.37 -2.23 -3.67 -6.00 -10.87 -0.44 -17.74 -17.22 -18.04 -7.19 -14.76 -10.97
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
189 252 221 298 368 431 522 555 677 628 458 381 378
155 200 190 236 299 354 437 443 522 551 464 447 396
Operating Profit 34 52 31 63 69 76 85 112 154 77 -6 -66 -18
OPM % 18% 21% 14% 21% 19% 18% 16% 20% 23% 12% -1% -17% -5%
0 -15 -0 -8 12 11 12 8 10 13 5 6 4
Interest 9 12 12 12 11 12 13 5 9 21 25 37 40
Depreciation 14 12 10 14 15 19 23 26 34 34 36 44 45
Profit before tax 11 12 8 29 56 56 61 89 121 35 -62 -141 -98
Tax % 22% -18% 95% 33% 37% 36% 23% 27% 26% 27% -24% -4%
9 15 0 19 35 36 47 65 90 26 -47 -135 -114
EPS in Rs 4.07 6.65 0.16 8.56 15.68 16.00 21.19 28.88 40.10 11.39 -20.98 -60.18 -50.96
Dividend Payout % 22% 16% 0% 15% 8% 8% 6% 5% 3% 12% 0% 0%
Compounded Sales Growth
10 Years: 4%
5 Years: -6%
3 Years: -17%
TTM: 2%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -10%
Stock Price CAGR
10 Years: 10%
5 Years: -10%
3 Years: -33%
1 Year: -42%
Return on Equity
10 Years: 5%
5 Years: 0%
3 Years: -14%
Last Year: -45%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 19 19 19 20 20 20 20 20 20 20 20 20 22
Reserves 96 117 99 118 150 183 227 289 376 399 349 214 391
79 93 127 127 125 176 99 188 280 341 494 555 367
85 128 84 69 119 83 227 182 221 219 111 92 102
Total Liabilities 279 358 329 334 413 461 572 678 897 979 974 880 883
130 127 94 103 115 167 194 213 340 318 386 499 500
CWIP 6 12 20 8 42 19 24 116 23 127 165 21 0
Investments 1 1 0 0 0 0 0 0 0 0 0 0 0
142 217 214 223 256 275 354 349 534 533 423 360 382
Total Assets 279 358 329 334 413 461 572 678 897 979 974 880 883

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
14 3 3 19 65 15 169 -8 23 74 10 -8
-16 -14 -16 -18 -49 -52 -74 -73 -104 -112 -135 -15
2 11 15 -1 -18 37 -95 81 80 38 125 24
Net Cash Flow -0 -0 2 1 -2 -0 0 0 0 -0 0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 86 143 132 136 122 103 112 123 148 90 135 141
Inventory Days 187 143 186 133 122 121 131 113 176 268 224 196
Days Payable 120 181 179 117 156 83 219 137 180 161 102 100
Cash Conversion Cycle 153 105 140 152 88 141 24 99 145 197 256 237
Working Capital Days 30 17 -29 0 -8 -2 8 4 12 -17 -1 -26
ROCE % 11% 20% 10% 20% 22% 20% 20% 22% 22% 8% -4% -13%

Shareholding Pattern

Numbers in percentages

12 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
66.76% 66.76% 66.76% 66.75% 66.75% 66.75% 66.75% 66.74% 66.74% 70.87% 70.87% 72.42%
2.19% 2.29% 1.95% 1.33% 1.28% 1.25% 1.03% 0.53% 1.20% 0.25% 0.02% 0.00%
9.57% 10.58% 10.15% 10.16% 9.74% 7.88% 3.37% 4.50% 5.40% 4.34% 4.26% 4.01%
21.49% 20.37% 21.13% 21.74% 22.22% 24.12% 28.85% 28.20% 26.64% 24.53% 24.84% 23.57%
No. of Shareholders 19,54517,80918,70318,72219,24419,84819,95519,72719,05718,68918,54918,276

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls